Capricor Therapeutics (NASDAQ:CAPR) received the Orphan Drug designation from the U.S. FDA for its lead cell therapy candidate, Deramiocel, to treat becker muscular dystrophy. With its orphan drug ...

The biotech industry faces a mix of longstanding and novel political challenges amid President Donald Trump’s second term.

Many parents said they were afraid of noninvasive ventilation, with some citing inaccurate concerns about ventilation devices.